{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T18:25:44Z","timestamp":1793989544208,"version":"4.8.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.yrtph.2026.106277","type":"journal-article","created":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T15:39:58Z","timestamp":1792769998000},"page":"106277","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Rethinking inhalation risk assessment: Integrating respiratory cell models with air-liquid interface exposure?"],"prefix":"10.1016","volume":"173","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6133-3368","authenticated-orcid":false,"given":"Martin J.D.","family":"Clift","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9958-8630","authenticated-orcid":false,"given":"Flemming R.","family":"Cassee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3423-7896","authenticated-orcid":false,"given":"Gordon","family":"McFiggans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7805-9366","authenticated-orcid":false,"given":"Barbara","family":"Rothen-Rutishauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yrtph.2026.106277_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113901","article-title":"Advanced human-relevant in vitro pulmonary platforms for respiratory therapeutics","volume":"176","author":"Artzy-Schnirman","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.yrtph.2026.106277_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.impact.2022.100439","article-title":"An inter-laboratory effort to harmonize the cell-delivered in vitro dose of aerosolized materials","volume":"28","author":"Bannuscher","year":"2022","journal-title":"NanoImpact"},{"issue":"4","key":"10.1016\/j.yrtph.2026.106277_bib3","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1021\/acsnano.9b06860","article-title":"Use of EpiAlveolar lung model to predict fibrotic potentical of multiwalled carbon nanotubes","volume":"14","author":"Barosova","year":"2020","journal-title":"ACS Nano"},{"issue":"15","key":"10.1016\/j.yrtph.2026.106277_bib4","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202006027","article-title":"Understanding the development, standardization, and validation process of alternative in vitro test methods for regulatory approval from a researcher perspective","volume":"17","author":"Bas","year":"2021","journal-title":"Small"},{"key":"10.1016\/j.yrtph.2026.106277_bib5","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/s41573-025-01182-9","article-title":"Application of new approach methodologies for nonclinical safety assessment of drug candidates","volume":"24","author":"Beilmann","year":"2025","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.yrtph.2026.106277_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.impact.2023.100466","article-title":"Transferability and reproducibility of exposed air-liquid interface co-culture lung models","volume":"31","author":"Braakhuis","year":"2023","journal-title":"NanoImpact"},{"issue":"1","key":"10.1016\/j.yrtph.2026.106277_bib7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3390\/toxics13010029","article-title":"Responses of an in vitro coculture alveolar model for the prediction of respiratory sensitizers (ALIsens\u00ae) following exposure to skin sensitizers and non-sensitizers","volume":"13","author":"Burla","year":"2024","journal-title":"Toxics"},{"issue":"3","key":"10.1016\/j.yrtph.2026.106277_bib8","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1177\/026119290503300313","article-title":"Guidance on good cell culture practice. A report of the second ECVAM task force on good cell culture practice","volume":"33","author":"Coecke","year":"2005","journal-title":"Altern. Lab. Anim."},{"issue":"2","key":"10.1016\/j.yrtph.2026.106277_bib9","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1177\/02611929251317434","article-title":"Accelerating animal replacement: how universities can lead \u2013 results of a one-day expert workshop in Zurich, Switzerland","volume":"53","author":"Deckha","year":"2025","journal-title":"Altern. Lab. Anim."},{"key":"10.1016\/j.yrtph.2026.106277_bib11","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1089\/aivt.2018.0002","article-title":"Through the looking glass: in vitro models for inhalation toxicology and interindividual variability in the airway","volume":"4","author":"Faber","year":"2018","journal-title":"Applied In Vitro Toxicology"},{"issue":"15","key":"10.1016\/j.yrtph.2026.106277_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202007628","article-title":"Non-animal strategies for toxicity assessment of nanoscale materials: role of adverse outcome pathways in the selection of endpoints","volume":"17","author":"Halappanavar","year":"2021","journal-title":"Small"},{"issue":"1","key":"10.1016\/j.yrtph.2026.106277_bib13","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12989-020-00344-4","article-title":"Adverse outcome pathways as a tool for the design of testing strategies to support the safety assessment of emerging advanced materials at the nanoscale","volume":"17","author":"Halappanavar","year":"2020","journal-title":"Part. Fibre Toxicol."},{"key":"10.1016\/j.yrtph.2026.106277_bib14","series-title":"3.0, Applying the Key Concepts to Build Confidence in NAMs","article-title":"Validation, qualification, and regulatory acceptance of new approach methodologies","author":"Harrill","year":"2024"},{"issue":"5","key":"10.1016\/j.yrtph.2026.106277_bib15","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1177\/026119290403200503","article-title":"A modular approach to the ECVAM principles on test validity","volume":"32","author":"Hartung","year":"2004","journal-title":"Altern. Lab. Anim."},{"key":"10.1016\/j.yrtph.2026.106277_bib16","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1126\/science.1188302","article-title":"Reconstituting organ-level lung functions on a chip","volume":"328","author":"Huh","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.yrtph.2026.106277_bib17","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/s41565-021-00911-6","article-title":"Towards FAIR nanosafety data","volume":"16","author":"Jeliazkova","year":"2021","journal-title":"Nat. Nanotechnol."},{"issue":"4","key":"10.1016\/j.yrtph.2026.106277_bib18","article-title":"A survey to assess animal methods bias in scientific publishing","volume":"40","author":"Krebs","year":"2023","journal-title":"ALTEX"},{"key":"10.1016\/j.yrtph.2026.106277_bib19","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1089\/aivt.2017.0034","article-title":"Air\u2013liquid interface in vitro models for respiratory toxicology research: consensus workshop and recommendations","volume":"4","author":"Lacroix","year":"2018","journal-title":"Applied In Vitro Toxicology"},{"issue":"11","key":"10.1016\/j.yrtph.2026.106277_bib20","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1007\/s00204-017-2045-3","article-title":"Adverse outcome pathways: opportunities, limitations and open questions","volume":"91","author":"Leist","year":"2017","journal-title":"Arch. Toxicol."},{"issue":"3","key":"10.1016\/j.yrtph.2026.106277_bib21","doi-asserted-by":"crossref","first-page":"341","DOI":"10.14573\/altex.1406091","article-title":"Consensus report on the future of animal-free systemic toxicity testing","volume":"31","author":"Leist","year":"2014","journal-title":"ALTEX"},{"key":"10.1016\/j.yrtph.2026.106277_bib22","series-title":"Series on Testing and Assessment No. 184","article-title":"Revised guidance document for developing and assessing adverse outcome pathways (AOPs)","year":"2013"},{"key":"10.1016\/j.yrtph.2026.106277_bib23","article-title":"Case study on the use of an integrated approach for testing and assessment (IATA) for new approach methodology (NAM) for refining inhalation risk assessment from point of contact toxicity of the pesticide, chlorothalonil","volume":"vol. 367","year":"2022"},{"key":"10.1016\/j.yrtph.2026.106277_bib24","series-title":"Guidance Document on Good in Vitro Method Practices (GIVIMP)","year":"2025"},{"key":"10.1016\/j.yrtph.2026.106277_bib25","unstructured":"PATROLS standard operating protocol (SOP) database. Available from:: https:\/\/www.patrols-h2020.eu\/publications\/sops\/index.php. [Accessed 3 June 2026]."},{"key":"10.1016\/j.yrtph.2026.106277_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2022.106337","article-title":"Human lung cell models to study aerosol delivery - considerations for model design and development","volume":"180","author":"Rothen-Rutishauser","year":"2023","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.yrtph.2026.106277_bib28","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12931-016-0358-z","article-title":"Regeneration of the lung: lung stem cells and the development of lung mimicking devices","volume":"17","author":"Schilders","year":"2016","journal-title":"Respir. Res."},{"key":"10.1016\/j.yrtph.2026.106277_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2023.108082","article-title":"New approach methodologies in human regulatory toxicology \u2013 not if, but how and when","volume":"178","author":"Schmeisser","year":"2023","journal-title":"Environ. Int."},{"key":"10.1016\/j.yrtph.2026.106277_bib30","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12989-017-0233-1","article-title":"On the pivotal role of dose for particle toxicology and risk assessment: exposorue is a poor surrogate for delivered dose","volume":"14","author":"Schmid","year":"2017","journal-title":"Part. Fibre Toxicol."},{"key":"10.1016\/j.yrtph.2026.106277_bib31","series-title":"Hayes' Principles and Methods of Toxicology","article-title":"Validation and regulatory acceptance of toxicological testing methods and strategies","author":"Stokes","year":"2014"},{"key":"10.1016\/j.yrtph.2026.106277_bib32","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1039\/C4LC01252F","article-title":"A lung-on-a-chip array with an integrated bio-inspired respiration mechanism","volume":"15","author":"Stucki","year":"2015","journal-title":"Lab Chip"},{"issue":"1","key":"10.1016\/j.yrtph.2026.106277_bib33","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/toxsci\/kfy053","article-title":"Air-liquid interface: relevant in vitro models for investigating air pollutant-induced pulmonary toxicity","volume":"164","author":"Upadhyay","year":"2018","journal-title":"Toxicol. Sci."},{"issue":"2","key":"10.1016\/j.yrtph.2026.106277_bib34","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/toxsci\/kfu200","article-title":"Adverse outcome pathway development II: best practices","volume":"142","author":"Villeneuve","year":"2014","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2026.106277_bib35","first-page":"137","article-title":"Effects of nitrogen dioxide on alveolar macrophages surviving in the gas phase. A new experimental model for the study of in vitro cytotoxicity of toxic gases","volume":"13","author":"Voisin","year":"1977","journal-title":"European Bulletin on Respiratory Physiology and Pathophysiology"},{"key":"10.1016\/j.yrtph.2026.106277_bib36","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3390\/ph18010113","article-title":"Two- and three-dimensional culture systems: respiratory in vitro tissue models for chemical scereening and risk-based decision making","volume":"18","author":"Wallace","year":"2025","journal-title":"Pharmaceuticals"}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230026002503?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230026002503?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T17:47:33Z","timestamp":1793987253000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0273230026002503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":34,"alternative-id":["S0273230026002503"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2026.106277","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rethinking inhalation risk assessment: Integrating respiratory cell models with air-liquid interface exposure?","name":"articletitle","label":"Article Title"},{"value":"Regulatory Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yrtph.2026.106277","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106277"}}